The Quantellect read.As of Nov 19, 2026, 8 active firms cover Merit Medical Systems Inc: 6 rate it Buy or better, 2 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets are tightly clustered, $83.00 to $106.00, so the covering firms are broadly aligned. The average target of $97.29 sits 13% above the current $85.95. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.02 next quarter toward $4.67 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS8 active firms
Buy
Strong Buy00%
Buy675%
Neutral225%
Sell00%
Strong Sell00%
Based on 8 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$97.29
+13.2% upside
Average target across 7 active firms as of Nov 19, 2026 vs $85.95 current
Highest Target$106.00
Average Target$97.29
Lowest Target$83.00
Detailed analyst forecasts for MMSI
Showing 1–7 of 7 named analysts shown · 8 active firms in the rating projection
As of Nov 19, 2026, 6 of 8 active firms rate MMSI a Buy (2 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
MMSI EPS & revenue forecast
EPS · NEXT QUARTER
$1.02
Range $0.99 – $1.05 · 9 analysts · +9% YoY
Next period, 9 analysts expect Merit Medical Systems Inc to earn $1.02 a share (range $0.99 – $1.05), versus $0.94 a year earlier. Full-year consensus is $4.35, growing to $4.67 the year after.
REVENUE · NEXT QUARTER
$409.5M
Range $405.0M – $414.9M · 9 analysts · +7% YoY
Revenue is expected to reach $409.5M (range $405.0M – $414.9M), +7.2% year-over-year. Full-year consensus is $1.6B, rising to $1.7B next year.
Top analysts covering Merit Medical Systems Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on MMSI.
#1
JB
Jayson Bedford
Raymond James · Rank #191
Buy
$100.00+16.3% to target
Overall win rate
44%
+ Follow
#2
Mike Matson
Needham · Rank #285
Buy
$101.00+17.5% to target
Overall win rate
36%
+ Follow
#3
Jason Bednar
Piper Sandler · Rank #360
Buy
$108.00+25.7% to target
Overall win rate
33%
+ Follow
#4
SE
Sam Eiber
BTIG
Buy
$110.00+28.0% to target
Coverage
—
+ Follow
#5
Robbie Marcus
JP Morgan
Buy
$95.00+10.5% to target
Coverage
—
+ Follow
MMSI stock forecast FAQ
What is MMSI's average 12-month price target?+
The 7 active firms with a live target average $97.29 for Merit Medical Systems Inc over the next 12 months, ranging from a $106.00 high to a $83.00 low, as of Nov 19, 2026.
Is MMSI stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 8 active firms as of Nov 19, 2026, 6 rate it Buy or Strong Buy, 2 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for MMSI?+
The Street-high target is $106.00 (Piper Sandler), and the Street-low is $83.00 (Wells Fargo). The average of all 7 active-firm targets is $97.29.
How many active Wall Street firms cover MMSI?+
8 active firms have a recognized rating on Merit Medical Systems Inc as of Nov 19, 2026, and 7 active firms carry a live 12-month price target.
Who is the most accurate analyst covering MMSI?+
Among analysts who currently cover MMSI, Jayson Bedford of Raymond James has the strongest overall Quantellect track record (Rank #191). Their current call is Buy with a $100.00 target.
What is Merit Medical Systems Inc's projected EPS for next quarter?+
The consensus estimate is $1.02 per share (range $0.99 – $1.05) across 9 analysts. Full-year EPS is projected at $4.35, rising to $4.67 the following year.
How much revenue is Merit Medical Systems Inc expected to report next quarter?+
Consensus revenue is $409.5M (range $405.0M – $414.9M). Full-year revenue is projected at $1.6B, growing to $1.7B next year.
Have analysts been upgrading or downgrading MMSI lately?+
As of Nov 19, 2026, 6 of 8 active firms rate MMSI a Buy (2 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their MMSI calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.